1. Home
  2. INFA vs BIO Comparison

INFA vs BIO Comparison

Compare INFA & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INFA
  • BIO
  • Stock Information
  • Founded
  • INFA 1993
  • BIO 1952
  • Country
  • INFA United States
  • BIO United States
  • Employees
  • INFA N/A
  • BIO N/A
  • Industry
  • INFA EDP Services
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • INFA Technology
  • BIO Industrials
  • Exchange
  • INFA Nasdaq
  • BIO Nasdaq
  • Market Cap
  • INFA 5.6B
  • BIO 6.2B
  • IPO Year
  • INFA 2021
  • BIO N/A
  • Fundamental
  • Price
  • INFA $24.01
  • BIO $226.40
  • Analyst Decision
  • INFA Hold
  • BIO Strong Buy
  • Analyst Count
  • INFA 15
  • BIO 4
  • Target Price
  • INFA $26.21
  • BIO $330.50
  • AVG Volume (30 Days)
  • INFA 6.9M
  • BIO 374.2K
  • Earning Date
  • INFA 05-07-2025
  • BIO 07-31-2025
  • Dividend Yield
  • INFA N/A
  • BIO N/A
  • EPS Growth
  • INFA 215.78
  • BIO N/A
  • EPS
  • INFA 0.00
  • BIO N/A
  • Revenue
  • INFA $1,655,308,000.00
  • BIO $2,541,100,000.00
  • Revenue This Year
  • INFA $5.12
  • BIO N/A
  • Revenue Next Year
  • INFA $4.81
  • BIO $3.69
  • P/E Ratio
  • INFA $3,761.36
  • BIO N/A
  • Revenue Growth
  • INFA 2.29
  • BIO N/A
  • 52 Week Low
  • INFA $15.65
  • BIO $215.38
  • 52 Week High
  • INFA $31.65
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • INFA 79.78
  • BIO 41.49
  • Support Level
  • INFA $18.78
  • BIO $220.31
  • Resistance Level
  • INFA $24.33
  • BIO $233.28
  • Average True Range (ATR)
  • INFA 0.80
  • BIO 8.26
  • MACD
  • INFA 0.52
  • BIO -1.40
  • Stochastic Oscillator
  • INFA 89.55
  • BIO 16.29

About INFA Informatica Inc.

Informatica Inc provides artificial intelligence (AI) enabled data management products on a cloud native platform that connects, manages, and unifies data across multi-vendor, multi-cloud, and hybrid systems at an enterprise scale. The company's platform includes a suite of interoperable data management products that leverage the shared services and metadata of the underlying platform, including products for Data Catalog, Data Integration & Engineering, API & Application Integration, Data Quality and Observability, Master Data Management, Customer and Business 360 Applications, Governance, Access and Privacy, and Data Marketplace., allowing customers to track and understand their data. Geographically, the company generates maximum revenue from North America.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: